Uvagrandol
Uvagrandol potently inhibits α-glucosidase and porcine lipase (IC50: 15.2 μM, 11.2 μM respectively) . Uvagrandol can be used in the research of Type 2 diabetes and obesity[1].
Product Specifications
UNSPSC
12352005
Target
Glycosidase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/uvagrandol.html
Solubility
10 mM in DMSO
Smiles
O=C(O[C@@H]1CC[C@H]([C@@H]([C@]1(CO)O)O)OC(C2=CC=CC=C2)=O)C3=CC=CC=C3
Molecular Formula
C21H22O7
Molecular Weight
386.40
References & Citations
[1]Galal KA, et al. Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial PfGSK3/PfPK6 with Activity against Blood Stage Parasites In Vitro. J Med Chem. 2022 Oct 13;65 (19) :13172-13197.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog